Seres Therapeutics to Announce First Quarter 2025 Financial Results and Business Updates on May 7, 2025
Provided By GlobeNewswire
Last update: Apr 23, 2025
CAMBRIDGE, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced that management will host a conference call and live audio webcast on May 7, 2025 at 8:30 a.m. ET to discuss first quarter 2025 financial results and provide business updates.
Read more at globenewswire.com
